|
Lucinactant市场分析报告
|
Discovery Laboratories Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... company is developing its products, Surfaxin (lucinactant), Surfaxin LS, and Aerosurf, to address the ...
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Linagliptin, Lipoic acid, Losartan , Losmapimod , Lucinactant, LY3127804, LY3819253, M5049, Maraviroc, MAS825 ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Linagliptin, Lipoic acid, Losartan , Losmapimod , Lucinactant, LY3127804, LY3819253, M5049, Maraviroc, MAS825 ...
Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review ... (ADHF) and cardiogenic shock; Aerosurf, a lucinactant for inhalation, and lyophilized KL4 ...
|
|
|